Background: Human skin aging is caused by several factors, such as UV irradiation,
| INTRODUCTION
Skin aging is a complex biologic process, influenced by a combination of intrinsic (genetics, cellular metabolism, hormones, and metabolic processes) and extrinsic (chronic light exposure, pollution, ionizing radiation, chemicals, and toxins) factors. 1, 2 Together, these factors lead to cumulative structural and physiologic alterations and progressive changes in each skin layer, as well as changes in skin appearance. Since intrinsic and extrinsic factors reduce collagen type I synthesis in fibroblasts and induce melanin in melanocytes, skin aging is characterized by wrinkling, roughness, dryness, and pigmented lesions. To inhibit and restore skin aging, a number of peptide-derived cosmeceutical ingredients are being developed. 3, 4 Collagen type I is the main component of skin layers. The amount of collagen is important to sustain the elasticity and strength of the skin. 5, 6 In the dermis, UVB exposure has been shown to tial components of the protein translation machinery. Although AIMP1 is associated with the translational machinery under normal conditions, AIMP1 is released from the MSC upon stress and then secreted into the extracellular space. 13 Secreted AIMP1 has various non-canonical functions, such as the regulation of angiogenesis, wound healing, and stem cell activation. 13 Interestingly, AIMP1 exhibits wound healing and stem cell activation effects. The secretion of AIMP1 is induced in the wound region and fluids. It may be released from TNF-a-stimulated macrophages and induces fibroblast proliferation and collagen synthesis in an ERK-dependent manner, showing rapid wound healing effects in mice. 15, 16 AIMP1 promotes the proliferation of bone-marrow-derived mesenchymal stem cells (BMMSCs) by activating the b-catenin/TCF complex via FGFR2-mediated activation of Akt, leading to an increase in MSCs in peripheral blood. 17 To develop AIMP1-derived peptides for cosmeceutical ingredients, several deletion fragments of AIMP1 were generated, and their activities toward the target cells were compared. AIMP1 promoted endothelial cell death and caspase-3 activation through its 101-114 amino acid regions, fibroblast proliferation through its 6-46 amino acid regions, and endothelial migration through its 114-192 amino acid regions, as revealed by deletion mapping. Thus, this work revealed that AIMP1 uses different regions for its diverse extracellular activities. 18 Although an AIMP1-derived peptide (AdP, amino acid region 
| Cytotoxicity assay
The CCK-8 assay was used to measure cytotoxicity under starved conditions, which are based on the conversion of a water-soluble
were grown in 96-well plates for 12 hours and treated with AdP under serum-starved conditions. After 48 hours, the epithelial cells were washed, and the extent of cell growth was assessed using a CCK-8 assay (Dojindo). CCK-8 solution (10 lL) was added to each well, followed by incubation for 2 hours at 37°C. The absorbance at 450 nm was determined by a multiplate reader (Synergy2, Biotek).
| TNF-a ELISA
RAW264.7 cells (1.5 9 10 4 ) were seeded on 24-well plate and treated with 10 ng/mL LPS and AdP. After 6 hours incubation, culture media were harvested and centrifugated for 10 minutes at 850 g.
TNF-a in supernatants was determined by TNF-a ELISA kit in accordance to the manufacturer instructions.
| Statistics
Statistical analysis was performed using unpaired two-tailed Student's t test. All results were presented as means AE standard deviation. P < .01 was considered statistically significant.
Relative Melanin Synthesis Inhibition
AdP (µg/ml) /Albutin 10 µM A, Melanocytes, B16F10 cells, pre-treated with a-MSH (0.5 lmol/L) for 24 h, were treated with AdP (0.01, 0.1, 1, 10 lg/mL) for 2 days. The amount of melanin was determined as described in methods. B, Melanocytes, pre-treated with a-MSH (0.5 lmol/L) for 24 h, were treated with AdP (0.1, 1, 10, 100 lg/mL) for 24 h. Tyrosinase activity was measured as described in methods. C. Melanocytes, induced by a-MSH (0.5 lmol/L), were treated with AdP (0.1, 1 lg/mL) and albutin (10 lmol/L) for 24 h. The amount of melanin, inhibited by AdP and albutin, was determined (left panel). For comparison, relative melanin synthesis inhibition was calculated as described methods (right panel). Error bars indicate the mean AE standard deviation from the average of three independent experiments. P value was determined by Student's t test. *P < .01 were determined to compare AdP with EGF. AdP, at 0.1 lg/mL, showed similar activity for the induction of collagen type I synthesis and fibroblast proliferation, when compared with EGF at 1 lg/ mL. AdP at 1 lg/mL showed 77% and 35%, and 74% more potent activity for collagen type I protein and mRNA induction, respectively, when compared with EGF at 1 lg/mL ( Figure 1C and D, lower panel). AdP at 1 lg/mL also showed 74% more potent activity for fibroblast proliferation when compared with EGF at 1 lg/ mL ( Figure 1E, right panel) . Together, these results demonstrated that AdP stimulates collagen type I synthesis and the proliferation of fibroblasts.
| Inhibitory effect of AdP on Melanin synthesis
Melanin synthesis is an important factor for skin pigmentation. To address the biologic function of AdP in skin pigmentation, the effect of AdP on melanin synthesis was examined. Since melanocytes are an important source of melanin synthesis, the potential for AdP to inhibit melanin synthesis was examined in AdP-treated melanocytes.
To activate melanin synthesis, melanocytes were pre-treated with a-
MSH (0.5 lmol/L). Melanin synthesis, induced by a-MSH, was (A) (C) (B)
F I G U R E 3 AdP shows safety and stability. A, Normal epithelial cells, Vero cells, were incubated with AdP (10, 100 lg/mL) for 48 h. Doxorubicin (50 lg/ mL) was used as positive control. After incubation, cytotoxicity was determined by CCK-8 assay. B, Macrophages, RAW264.7 cells, were incubated with AdP (10, 100 lg/mL) for 6 h. LPS (10 ng/mL) was used as positive control. To check TNF-a secretion, media were harvested and centrifuged. TNF-a level was determined in harvested media by ELISA. C, AdP was incubated for 3 months at indicated temperature. Fibroblasts were treated with incubated AdP (1, 10 lg/mL) for 24 h. The amount of collagen type I in fibroblasts was measured by ELISA in cultured media. Error bars indicate the mean AE standard deviation from the average of three independent experiments. P value was determined by Student's t test. *P < .01 inhibited by AdP treatment in a dose-dependent manner (Figure 2A) .
To determine the mechanism of the inhibitory effect of AdP on melanin synthesis, a tyrosinase enzyme activity assay was carried out.
When AdP was treated with mushroom tyrosinase, tyrosinase enzyme activity decreased in a dose-dependent manner ( Figure 2B ). 
| Characterization of AdP for development as cosmeceutical ingredient
To develop AdP as a cosmeceutical ingredient, the safety of AdP was examined. Since AIMP1 has apoptotic and pro-inflammatory effects, the cytotoxicity and immunogenicity of AdP were tested.
Although the apoptotic and pro-inflammatory domains of AIMP were removed in AdP, 14 the cytotoxicity and pro-inflammatory 
| DISCUSSION
The most common dermatologic problem is skin aging. Skin aging phenotypes, such as wrinkles and pigmentation, lead to an increase in the demand for anti-aging products in the cosmetic market.
Research on skin aging has advanced over the decades to satisfy the demand of the cosmetic market. 15 Although many cosmetic ingredients have been developed and used in cosmetics, the demand for a suitable bioactive ingredient has increased.
A number of pharmaceutical materials with potent biologic activity toward the skin have also been tested for cosmetic products.
Among pharmaceutical materials, safe ingredients are recognized as cosmeceuticals and used in cosmetics. Since the usage of cosmetics is not tightly regulated, the safety of cosmeceutical ingredients is the most important factor. For example, peptides, growth factors, and antioxidants are used as cosmeceuticals. 16 EGF is a representative cosmeceutical ingredient and activates fibroblasts to produce collagen. Although EGF has anti-aging activity and anti-wrinkle effects, some have reported adverse activity at a high dose of EGF. Highdose EGF treatment induced melanoma in a mouse model. Therefore, the concentration of EGF in cosmetics is regulated. 19 Nevertheless, cosmeceutical ingredients show more potent biologic activity than classical cosmetic ingredients. Thus, a new, safe cosmeceutical ingredient is needed.
AIMP1 is associated with the multi-aminoacyl-tRNA synthetase complex. When it was discovered, it was identified as a cofactor protein that provides an efficient aminoacyl-tRNA synthesis trafficking channel for translation. 20 Moreover, the level of AIMP1 is increased in wounded skin, and AIMP1 plays a significant role in wound healing, 17 an AIMP1-derived peptide (AdP, amino acid region 6-46, sh-oligopeptide 5/sh-oligoepeptide 5 SP) has the potential to be used as a cosmeceutical. AdP showed more potent activity for promoting fibroblast proliferation and collagen type I synthesis than EGF, a representative cosmeceutical ingredient. AdP also showed an anti-pigmentation effect, inhibiting melanin synthesis through tyrosinase inhibition. Compared with other cosmeceutical ingredients, such as growth factors and peptides with a single activity for anti-aging, AdP is a novel cosmeceutical ingredient that has dual functions with anti-wrinkle and whitening effects. As some materials interact with each other and trigger adverse effects, the use of fewer ingredients is better for multifunctional cosmetic products. Thus, AdP, with its dual functions, is an alternative ingredient that can be used to reduce the number of components in multifunctional cosmetics.
As AIMP1 shows anti-tumorigenic activity, 21 AdP could suppress tumorigenicity, unlike EGF or TGF-b1. Besides the anti-tumorigenic effect of AdP, AdP was also safe in terms of cytotoxicity and immunogenicity. In conclusion, AdP could be beneficial for anti-aging and as a safe cosmeceutical ingredient.
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